Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Marker Therapeutics Inc market cap is $18.17M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Marker Therapeutics Inc 52 week high is $2.46 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Marker Therapeutics Inc 52 week low is $0.8101 as of November 22, 2026.
Marker Therapeutics Inc stock price today is $1.09.
Marker Therapeutics Inc stock price yesterday was $1.32.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Marker Therapeutics Inc's P/E ratio is -2.39.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Marker Therapeutics Inc P/B ratio is 1.7304.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Marker Therapeutics Inc 50-day moving average is $1.03.